Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma
Ritu Chaudhary(Moffitt Cancer Center), Christine H. Chung(Moffitt Cancer Center), Jude Masannat(Moffitt Cancer Center), Nelusha Amaladas(Eli Lilly (United States)), Aik Choon Tan(Colorado School of Public Health), Keegan P. McCleary‐Sharpe(Moffitt Cancer Center), José R. Conejo-García(Duke University), Feifei Song(Moffitt Cancer Center), Xuefeng Wang(Xuzhou Medical College), Wenjuan Wu(Eli Lilly (United States)), Juan C. Hernandez‐Prera(Moffitt Cancer Center), Gerald E. Hall(Eli Lilly (United States)), Robbert J.C. Slebos(University of Iowa)
Cited by 26
Related Papers
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
|Cell Metabolism|2012|1.1k